{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:47:09Z","timestamp":1780656429318,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bioorg.2020.104075","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T20:48:03Z","timestamp":1594154883000},"page":"104075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Synthesis of 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide and 3-oxo-3,4-dihydrobenzo[b][1,4]oxazine-8-carboxamide derivatives as PARP1 inhibitors"],"prefix":"10.1016","volume":"102","author":[{"given":"Xuwei","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday Kiran","family":"Velagapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi","family":"Gobbooru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Shilpa","family":"Kommaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woon-Kai","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjai Kumar","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaji T.","family":"Talele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2020.104075_b0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.sbi.2013.01.003","article-title":"PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis","volume":"23","author":"Langelier","year":"2013","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104075_b0010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1158\/1078-0432.CCR-16-1274","article-title":"A phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms, and chronic myelomonocytic leukemia","volume":"23","author":"Pratz","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104075_b0015","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1158\/1078-0432.CCR-17-1590","article-title":"A phase I clinical trial of the poly(ADP-ribose) polymerase inhibitor veliparib and weekly topotecan in patients with solid tumors","volume":"24","author":"Wahner Hendrickson","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"7035","key":"10.1016\/j.bioorg.2020.104075_b0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"issue":"7035","key":"10.1016\/j.bioorg.2020.104075_b0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bioorg.2020.104075_b0030","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/0008-5472.CAN-08-0088","article-title":"Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance","volume":"68","author":"Swisher","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104075_b0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/2159-8290.CD-12-0514","article-title":"Mechanisms of resistance to PARP inhibitors-three and counting","volume":"3","author":"Fojo","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2020.104075_b0040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fonc.2015.00222","article-title":"Successes and challenges of PARP inhibitors in cancer therapy","volume":"5","author":"Ricks","year":"2015","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.bioorg.2020.104075_b0045","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1021\/acs.jmedchem.8b01709","article-title":"Design and synthesis of Poly(ADP-ribose) polymerase inhibitors: Impact of adenosine pocket-binding motif appendage to the 3-oxo-2,3-dihydrobenzofuran-7-carboxamide on potency and selectivity","volume":"62","author":"Velagapudi","year":"2019","journal-title":"J. Med. Chem."},{"issue":"6486","key":"10.1016\/j.bioorg.2020.104075_b0050","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax6367","article-title":"Structural basis for allosteric PARP-1 retention on DNA breaks","volume":"368","author":"Zandarashvili","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bioorg.2020.104075_b0055","doi-asserted-by":"crossref","unstructured":"S.L. Dixon, A.M. Smondyrev, E.H. Knoll, S.N. Rao, D.E. Shaw, R.A. Friesner, PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results, J. Comput. Aided Mol. Des. 20(10-11) (2006) 647-671. DOI: 10.1007\/s10822-006-9087-6.","DOI":"10.1007\/s10822-006-9087-6"},{"issue":"22","key":"10.1016\/j.bioorg.2020.104075_b0060","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1021\/jm901188v","article-title":"Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors","volume":"52","author":"Jones","year":"2009","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2020.104075_b0065","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1021\/jm100012m","article-title":"Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic","volume":"53","author":"Ferraris","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104075_b0070","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejmech.2012.02.001","article-title":"Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors","volume":"50","author":"Kulkarni","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2020.104075_b0075","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1021\/jm5002502","article-title":"Discovery and structure-activity relationship of novel 2,3-dihydrobenzofuran-7-carboxamide and 2,3-dihydrobenzofuran-3(2H)-one-7-carboxamide derivatives as poly(ADP-ribose)polymerase-1 inhibitors","volume":"57","author":"Patel","year":"2014","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2020.104075_b0080","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1016\/j.bmc.2015.05.047","article-title":"Orally active ghrelin receptor inverse agonists and their actions on a rat obesity model","volume":"23","author":"Takahashi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2020.104075_b0085","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1021\/jo00195a008","article-title":"Synthesis, thermal stability, and chemiluminescence properties of the dioxetanes derived from 1,4-dioxins","volume":"49","author":"Adam","year":"1984","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.104075_b0090","doi-asserted-by":"crossref","unstructured":"C. Rajitha, P.K. Dubey, V. Sunku, V.R. Veeramaneni, M. Pal, H3PO4\/(CF3CO)2O mediated acylation followed by Hurd\u2013Mori reaction: Synthesis of novel 1,2,3-thiadiazol derivatives, J. Het. Chem. 50(3) (2013) 630-637. DOI: doi:10.1002\/jhet.1625.","DOI":"10.1002\/jhet.1625"},{"key":"10.1016\/j.bioorg.2020.104075_b0095","doi-asserted-by":"crossref","unstructured":"T.M. Kuroita, N.; Sano, M.; Kanzaki, K.; Inaba, K.; Kawakita, T., Benzoxazines. II. Synthesis, conformational analysis, and structure--activity relationships of 3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide derivatives as potent and long-acting serotonin-3 (5-HT3) receptor antagonists, Chem. Pharm. Bull. 44(11) (1996) 2051-2060. DOI: 10.1248\/cpb.44.2051.","DOI":"10.1248\/cpb.44.2051"},{"issue":"1995091","key":"10.1016\/j.bioorg.2020.104075_b0100","first-page":"79","article-title":"Preparation of benzamide analogs as poly(ADP-ribose) polymerase inhibitors","volume":"A1","author":"Griffin","year":"1995","journal-title":"PCT Int. Appl."},{"key":"10.1016\/j.bioorg.2020.104075_b0105","doi-asserted-by":"crossref","unstructured":"J.C. Ame, V. Rolli, V. Schreiber, C. Niedergang, F. Apiou, P. Decker, S. Muller, T. Hoger, J. Menissier-de Murcia, G. de Murcia, PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase, J. Biol. Chem. 274(25) (1999) 17860-17868. DOI: 10.1074\/jbc.274.25.17860.","DOI":"10.1074\/jbc.274.25.17860"},{"key":"10.1016\/j.bioorg.2020.104075_b0110","doi-asserted-by":"crossref","unstructured":"J.M. Rodriguez-Vargas, L. Nguekeu-Zebaze, F. Dantzer, PARP3 comes to light as a prime target in cancer therapy, Cell cycle (Georgetown, Tex.) 18(12) (2019) 1295-1301. DOI: 10.1080\/15384101.2019.1617454.","DOI":"10.1080\/15384101.2019.1617454"},{"issue":"12","key":"10.1016\/j.bioorg.2020.104075_b0115","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1111\/cas.13805","article-title":"RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model","volume":"109","author":"Mizutani","year":"2018","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.bioorg.2020.104075_b0120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ardp.201000350","article-title":"Identification of novel matrix metalloproteinase inhibitors by screening of phenol fragments library","volume":"344","author":"Rubino","year":"2011","journal-title":"Arch. Pharm."},{"issue":"2","key":"10.1016\/j.bioorg.2020.104075_b0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cmdc.200500023","article-title":"1-(1-Phenethylpiperidin-4-yl)-1-phenylethanols as potent and highly selective 5-HT2A antagonists","volume":"1","author":"Heinrich","year":"2006","journal-title":"ChemMedChem"},{"issue":"23","key":"10.1016\/j.bioorg.2020.104075_b0130","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1016\/j.tetasy.2003.09.012","article-title":"A short entry to enantiopure 2-substituted 1,4-benzodioxanes by efficient resolution methods","volume":"14","author":"Bolchi","year":"2003","journal-title":"Tetrahedron Asymmetry"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104075_b0135","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/jm049433t","article-title":"Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent sigma ligands","volume":"48","author":"Costantino","year":"2005","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2020.104075_b0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bmc.2008.11.060","article-title":"Synthesis of novel 1,4-benzoxazin-3-one derivatives as inhibitors against tyrosine kinases","volume":"17","author":"Honda","year":"2009","journal-title":"Bioorg. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820313729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820313729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:09:57Z","timestamp":1758614997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820313729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":28,"alternative-id":["S0045206820313729"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104075","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of 2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide and 3-oxo-3,4-dihydrobenzo[b][1,4]oxazine-8-carboxamide derivatives as PARP1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104075"}}